Whalesbook
Biocon ne QIP se ₹4,150 Crore secure kiye
Biocon Ltd. ne Thursday ko bataya ki unhone apna Qualified Institutional Placement (QIP) fundraising safaltapoorvak band kar diya hai, jismein 11.26 crore se zyada equity shares issue karke ₹4,150 crore raise kiye gaye. Ye placement, ₹368.35 per share par kiya gaya, jo pichhle din ke closing price se thoda kam tha.
Bade Institutional Investors ne Fundraise ko boost kiya
Key Indian mutual fund houses, jismein SBI Mutual Fund aur ICICI Prudential Mutual Fund dwara manage kiye jaane wale funds shamil hain, ne bade star par invest kiya. Unhone offered shares ka lagbhag do-tihaai hissa acquire kiya. Mirae Asset Mutual Fund ne bhi is placement mein participate kiya.
Biologics Acquisition ke liye Proceeds ka Strategic Use
Is badi capital infusion ka mukhya uddeshya Biocon Biologics mein Mylan Inc. ki stake acquire karne ke liye required cash consideration ko pura karna hai. Kuchh hissa Biocon Biologics mein Compulsorily Convertible Debentures (CCDs) acquire karne se incurred debt ko clear karne ke liye bhi use kiya jayega, aur baki funds general corporate needs ke liye rakhe jayenge.
Market Context aur Future Outlook
Ye kadam Biocon ki ownership consolidate karne ki strategy ka hissa hai, jiska aim Biocon Biologics ko wholly-owned subsidiary banana hai. Company ne pehle hi ₹4,500 crore tak raise karne ki approval secure ki thi taaki is strategic acquisition ko facilitate kiya ja sake, jismein Mylan ko $400 million ka payment shamil hai. Biocon ke shares Wednesday ko 0.4% badhkar ₹378.9 par band hue the. Pichhle ek saal mein stock ne flat performance dikhai hai, is capital raise ko future growth trajectory ke liye ek mahatvapurn event banata hai.